News

AffyImmune Presents Preclinical Data on AIC100 Affinity-Tuned CAR T Targeting ICAM-1 in Additional Solid Tumor Types at AACR 2024

AffyImmune Therapeutics Announces Clinical and Regulatory Advisory Board to Support Development of AIC100 in Solid Tumors

AffyImmune Therapeutics to Present Poster at 2024 American Association for Cancer Research Annual Meeting

AffyImmune Therapeutics Awarded Best Oncology R&D Advance Scrip Award 2023

AffyImmune Therapeutics to Present at 2023 Cell & Gene Meeting on the Mesa

AffyImmune Therapeutics Named 2023 Scrip Award Finalist for Best Oncology R&D Advance